NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shanghai Bendao Gene Technology

Shanghai Bendao Gene Technology

Private
ShanghaiHealthcare & Life Scienceshttps://www.bdgenetherapeutics.com/

Last Round

Strategic

Apr 2, 2026

Total Funding Raised

$66.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Shanghai Bendao Gene Technology is a biotechnology company that develops gene therapies for major diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapygene editinggene delivery platformCRISPR gene editingin vivo gene editingbiotech technology licensingcell and gene therapymRNA therapylentiviral vectorclinical-stage biotechviral vectorVLP-mRNA deliveryophthalmology gene therapyone-shot cureHerpes Simplex Virus Keratitisβ-thalassemia

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Bendao Gene Technology Comps

Public and private peers based on sector, stage, and business model.

Shanghai Bendao Gene Technology comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanghai Bendao Gene Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 2, 2026
Series BJun 27, 2023
Series AApr 13, 2021
Early FundingMar 1, 2020
StrategicJun 26, 2019

Shanghai Bendao Gene Technology Investors

Notable investors and investment history

Shanghai Bendao Gene Technology investors
InvestorRounds
Sunland FundSeries B
Emerging Technology PartnersSeries A
Longmen CapitalSeries A
Hermed CapitalSeries B
Tsinghua Holdings CapitalSeries A
Keytone VenturesEarly Funding
Inno Angel FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors grew 83% MoM.

  • Apr 16, 2026

    Monthly visitors increased 163% MoM.

Shanghai Bendao Gene Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Bendao Gene Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Bendao Gene Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range1
Year Founded2018
Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.